ASML:EURONEXT AMSTERDAMASML Holding NV Analysis
Data as of 2026-08-31 - not real-time
$1,696.16
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind ASML Holding N.V. is neutral at $1,696.16, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 2.9%. RSI sits at 43.4, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $1,582.00 and resistance at $1,896.35.
Multiples put this in overvalued territory: 57.1 times earnings against the sector's 35.7. Sell-side targets cluster 26.5% above the current quote. Revenue is growing at 21.3% on a 30.1% profit margin. The 0.54% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 42.5%, a beta of 2.31 and a maximum drawdown of 22.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Multiples put this in overvalued territory: 57.1 times earnings against the sector's 35.7. Sell-side targets cluster 26.5% above the current quote. Revenue is growing at 21.3% on a 30.1% profit margin. The 0.54% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 42.5%, a beta of 2.31 and a maximum drawdown of 22.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
ASML stock is being steered by heavy Q2 2026 share buybacks and a firm Q3 2026 outlook, while one inASML Holding NV ASML reports robust Q2 results, exceeding sales and margin expectations, while addressing challenges in...Semiconductor equipment manufacturer ASML ASML has announced an interim dividend of €1.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 1464.04
- MACD momentum is negative
- 30-day volatility of 42.5%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 57.1 versus sector average of 35.7
- Trading above the 200-day average of 1464.04
- Analyst targets imply +26.5% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 57.1 versus sector average of 35.7
- Analyst targets imply +26.5% versus the current price
- Profit margin of 30.1% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth21.30%
Profit Margin30.11%
P/E Ratio57.1
ROE53.94%
ROA16.45%
Debt/Equity9.09
P/B Ratio1423.2
Op. Cash Flow$11.5B
Free Cash Flow$8.4B
Industry P/E35.7
Technical Analysis
TrendNeutral
RSI43.4
Support$1,582.00
Resistance$1,896.35
MA 20$1,756.30
MA 50$1,768.21
MA 200$1,464.04
MACDBearish
VolumeStable
Fear & Greed Index94.25
Valuation
Fair Value$684.52
Target Price$2,145.38
Upside/Downside26.48%
GradeOvervalued
TypeGrowth
Dividend Yield0.54%
Risk Assessment
Beta2.31
Volatility42.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.